Head-to-head trial shows Eli Lilly’s oral GLP-1 orforglipron outperforms oral semaglutide

February 26, 2026 4 min read Add Us On GoogleAdd SciAm Head-to-head trial pitting Eli Lilly’s oral GLP-1 against oral semaglutide underscores efficacy of weight-loss pills A new trial found that Eli Lilly’s GLP-1 pill resulted in greater reductions in blood sugar levels and weight than oral semaglutide did, but fewer people stayed on it…

Read More

Jack Dorsey’s Block cuts 40% of staff, 4,000+ people — and yes, it’s because of AI efficiencies

Former Twitter co-founder Jack Dorsey’s new company Block — the parent of merchants payment system Square, mobile peer-to-peer payments Cash App, music streamer Tidal, and open source AI agentic system Goose — is sending shockwaves across the business world tonight after announcing a more than 40% headcount, cutting its workforce by more than 4,000 people…

Read More
Back To Top